These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17545350)

  • 1. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial.
    Thomson RG; Eccles MP; Steen IN; Greenaway J; Stobbart L; Murtagh MJ; May CR
    Qual Saf Health Care; 2007 Jun; 16(3):216-23. PubMed ID: 17545350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.
    Man-Son-Hing M; Laupacis A; O'Connor AM; Biggs J; Drake E; Yetisir E; Hart RG
    JAMA; 1999 Aug; 282(8):737-43. PubMed ID: 10463708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.
    Man-Son-Hing M; Gage BF; Montgomery AA; Howitt A; Thomson R; Devereaux PJ; Protheroe J; Fahey T; Armstrong D; Laupacis A
    Med Decis Making; 2005; 25(5):548-59. PubMed ID: 16160210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis.
    Protheroe J; Fahey T; Montgomery AA; Peters TJ
    West J Med; 2001 May; 174(5):311-5. PubMed ID: 11342503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation.
    Fatima S; Holbrook A; Schulman S; Park S; Troyan S; Curnew G
    Thromb Res; 2016 Sep; 145():143-8. PubMed ID: 27388221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis.
    Protheroe J; Fahey T; Montgomery AA; Peters TJ
    BMJ; 2000 May; 320(7246):1380-4. PubMed ID: 10818030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative methods in a randomised controlled trial: the role of an integrated qualitative process evaluation in providing evidence to discontinue the intervention in one arm of a trial of a decision support tool.
    Murtagh MJ; Thomson RG; May CR; Rapley T; Heaven BR; Graham RH; Kaner EF; Stobbart L; Eccles MP
    Qual Saf Health Care; 2007 Jun; 16(3):224-9. PubMed ID: 17545351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
    Lip GY
    J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.
    Gage BF; Cardinalli AB; Albers GW; Owens DK
    JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability of patient decision aids for stroke prevention in atrial fibrillation: A systematic review.
    O'Neill ES; Grande SW; Sherman A; Elwyn G; Coylewright M
    Am Heart J; 2017 Sep; 191():1-11. PubMed ID: 28888264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation.
    Thomson R; Robinson A; Greenaway J; Lowe P;
    Qual Saf Health Care; 2002 Mar; 11(1):25-31. PubMed ID: 12078365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.